SGLT2 Inhibitors Market for Diabetes Treatment Analysis: Emerging Therapies and Forecast
The SGLT2 Inhibitors Market for Diabetes Treatment is gaining momentum as diabetes becomes an increasingly important chronic healthcare challenge. The market is expected to increase from USD 6.6 billion in 2025 to USD 15.0 billion by 2035 at a CAGR of 8.6%, supported by rising patient populations, greater treatment awareness, and advances in drug development. Technology and pharmaceutical...
0 Comments 0 Shares 143 Views 0 Reviews